drugset / Trial / NCT07094932
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBD09
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, multiple dose trial of TBD09, administered to healthy adult participants to assess safety, tolerability, and pharmacokinetics up to 84 days of fixed daily dosing of TBD09. The trial will be conducted with two cohorts, with participants enrolled in parallel and randomized to receive either TBD09 or placebo.
Timeline
- Start
- 2025-09-03
- Primary completion
- 2026-01-11
- Completion
- 2026-01-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TBD09 | Unknown | — | Oral |
Indications
No indication recorded.